George D. Dalton

1.5k total citations
19 papers, 1.2k citations indexed

About

George D. Dalton is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, George D. Dalton has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in George D. Dalton's work include Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Pancreatic function and diabetes (4 papers). George D. Dalton is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Pancreatic function and diabetes (4 papers). George D. Dalton collaborates with scholars based in United States, South Korea and Argentina. George D. Dalton's co-authors include A­llyn C. Howlett, Lawrence C. Blume, William L. Dewey, Jian Xie, Sung-Wan An, Chou‐Long Huang, Anna Mae Diehl, Kuo Du, Bahar Salimian Rizi and Jeongeun Hyun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Journal of Neurochemistry.

In The Last Decade

George D. Dalton

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George D. Dalton United States 14 473 380 353 179 160 19 1.2k
N. Sakamoto Japan 20 105 0.2× 252 0.7× 125 0.4× 108 0.6× 120 0.8× 60 1.2k
Bei Song China 18 142 0.3× 393 1.0× 124 0.4× 88 0.5× 161 1.0× 38 1.1k
Michael A. Kirschenbaum United States 23 215 0.5× 503 1.3× 59 0.2× 295 1.6× 180 1.1× 67 1.4k
Jeremy D. Gale United States 23 64 0.1× 290 0.8× 246 0.7× 47 0.3× 320 2.0× 51 1.4k
Fangwen Rao United States 26 56 0.1× 791 2.1× 335 0.9× 136 0.8× 221 1.4× 61 1.9k
Victoria Velarde Chile 22 105 0.2× 831 2.2× 143 0.4× 55 0.3× 81 0.5× 46 1.6k
Pierre Corvol France 9 291 0.6× 306 0.8× 85 0.2× 37 0.2× 261 1.6× 9 1.8k
Chrisanthi A. Karanikas United States 12 371 0.8× 477 1.3× 144 0.4× 9 0.1× 299 1.9× 21 1.5k
Eiji Sugaru Japan 14 49 0.1× 242 0.6× 151 0.4× 45 0.3× 126 0.8× 22 1.3k
Boris Julien France 17 1.1k 2.3× 466 1.2× 414 1.2× 12 0.1× 493 3.1× 20 2.4k

Countries citing papers authored by George D. Dalton

Since Specialization
Citations

This map shows the geographic impact of George D. Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George D. Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George D. Dalton more than expected).

Fields of papers citing papers by George D. Dalton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George D. Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George D. Dalton. The network helps show where George D. Dalton may publish in the future.

Co-authorship network of co-authors of George D. Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of George D. Dalton. A scholar is included among the top collaborators of George D. Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George D. Dalton. George D. Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dalton, George D., Stephen K. Siecinski, Viktoriya D. Nikolova, et al.. (2024). Transcriptome analysis identifies an ASD-Like phenotype in oligodendrocytes and microglia from C58/J amygdala that is dependent on sex and sociability. Behavioral and Brain Functions. 20(1). 14–14. 5 indexed citations
2.
Chen, Tianyi, George D. Dalton, Seh‐Hoon Oh, et al.. (2022). Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology. 15(4). 949–970. 19 indexed citations
3.
Dalton, George D., Seh‐Hoon Oh, Linda Tang, et al.. (2021). Hepatocyte activity of the cholesterol sensor smoothened regulates cholesterol and bile acid homeostasis in mice. iScience. 24(9). 103089–103089. 6 indexed citations
4.
Dalton, George D., et al.. (2020). CB1 Cannabinoid Receptors Stimulate Gβγ-GRK2-Mediated FAK Phosphorylation at Tyrosine 925 to Regulate ERK Activation Involving Neuronal Focal Adhesions. Frontiers in Cellular Neuroscience. 14. 176–176. 14 indexed citations
5.
Du, Kuo, Jeongeun Hyun, Richard T. Premont, et al.. (2018). Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Gastroenterology. 154(5). 1465–1479.e13. 267 indexed citations
6.
7.
Dalton, George D., Jian Xie, Sung-Wan An, & Chou‐Long Huang. (2017). New Insights into the Mechanism of Action of Soluble Klotho. Frontiers in Endocrinology. 8. 323–323. 158 indexed citations
8.
Dalton, George D., Sung-Wan An, Nicole Nischan, et al.. (2017). Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling. Proceedings of the National Academy of Sciences. 114(4). 752–757. 71 indexed citations
9.
Dalton, George D., Lynda J. Peterson, & A­llyn C. Howlett. (2013). CB1 cannabinoid receptors promote maximal FAK catalytic activity by stimulating cooperative signaling between receptor tyrosine kinases and integrins in neuronal cells. Cellular Signalling. 25(8). 1665–1677. 27 indexed citations
10.
Blume, Lawrence C., Caroline E. Bass, Steven R. Childers, et al.. (2013). Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems. Journal of Neurochemistry. 124(6). 808–820. 46 indexed citations
11.
Dalton, George D. & A­llyn C. Howlett. (2011). Cannabinoid CB1receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells. British Journal of Pharmacology. 165(8). 2497–2511. 72 indexed citations
12.
Howlett, A­llyn C., Lawrence C. Blume, & George D. Dalton. (2010). CB1 Cannabinoid Receptors and their Associated Proteins. Current Medicinal Chemistry. 17(14). 1382–1393. 221 indexed citations
13.
Dalton, George D., et al.. (2009). Signal Transduction via Cannabinoid Receptors. CNS & Neurological Disorders - Drug Targets. 8(6). 422–431. 77 indexed citations
14.
Dalton, George D., et al.. (2008). Effect of physician strategies for coping with the US medical malpractise crisis on healthcare delivery and patient access to healthcare. Public Health. 122(10). 1051–1060. 9 indexed citations
15.
Dalton, George D., et al.. (2007). Improvements in the safety of patient care can help end the medical malpractice crisis in the United States. Health Policy. 86(2-3). 153–162. 19 indexed citations
16.
Sim‐Selley, Laura J., et al.. (2006). Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration. Molecular Pharmacology. 70(3). 986–996. 89 indexed citations
17.
Dalton, George D. & William L. Dewey. (2006). Protein kinase inhibitor peptide (PKI): A family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. Neuropeptides. 40(1). 23–34. 117 indexed citations
18.
Dalton, George D., Forrest L. Smith, Paul A. Smith, & William L. Dewey. (2005). Alterations in brain Protein Kinase A activity and reversal of morphine tolerance by two fragments of native Protein Kinase A inhibitor peptide (PKI). Neuropharmacology. 48(5). 648–657. 18 indexed citations
19.
Dalton, George D., Forrest L. Smith, Paul A. Smith, & William L. Dewey. (2005). Chronic Δ9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering Protein Kinase A activity in mouse brain and spinal cord. Biochemical Pharmacology. 70(1). 152–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Sakamoto Breakdown of academic impact, for papers by Bei Song Breakdown of academic impact, for papers by Michael A. Kirschenbaum Breakdown of academic impact, for papers by Jeremy D. Gale Breakdown of academic impact, for papers by Fangwen Rao Breakdown of academic impact, for papers by Victoria Velarde Breakdown of academic impact, for papers by Pierre Corvol Breakdown of academic impact, for papers by Chrisanthi A. Karanikas Breakdown of academic impact, for papers by Eiji Sugaru Breakdown of academic impact, for papers by Boris Julien
Rankless by CCL
2026